Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 44 | $11,408,670 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
05 Mar 2024 16:08 | NVCR | NovoCure Ltd | LEONARD FRANK X | EVP, Pres., Novocure Oncology | 04 Mar 2024 | Sale | 840 | 16.01 | 13,448 | D |
05 Mar 2024 16:08 | NVCR | NovoCure Ltd | LEONARD FRANK X | EVP, Pres., Novocure Oncology | 01 Mar 2024 | Sale | 1,679 | 16.0269 | 26,909 | D |
29 Feb 2024 16:38 | NVCR | NovoCure Ltd | LEONARD FRANK X | EVP, Pres., Novocure Oncology | 28 Feb 2024 | Sale | 2,078 | 16.1428 | 33,545 | D |
07 Mar 2023 16:52 | NVCR | NovoCure Ltd | LEONARD FRANK X | President, CNS Cancers US | 07 Mar 2023 | Sale | 2,315 | 75.5937 | 174,999 | D |
07 Mar 2023 16:52 | NVCR | NovoCure Ltd | LEONARD FRANK X | President, CNS Cancers US | 07 Mar 2023 | Sale | 6,003 | 74.9968 | 450,206 | D |
07 Mar 2023 16:52 | NVCR | NovoCure Ltd | LEONARD FRANK X | President, CNS Cancers US | 03 Mar 2023 | Sale | 888 | 76.1594 | 67,630 | D |
07 Mar 2023 16:52 | NVCR | NovoCure Ltd | LEONARD FRANK X | President, CNS Cancers US | 03 Mar 2023 | Sale | 4,403 | 76.1594 | 335,330 | D |
06 Mar 2023 16:37 | NVCR | NovoCure Ltd | LEONARD FRANK X | President, CNS Cancers US | 03 Mar 2023 | Sale | 2,059 | 77.6391 | 159,859 | D |
06 Mar 2023 16:37 | NVCR | NovoCure Ltd | LEONARD FRANK X | President, CNS Cancers US | 02 Mar 2023 | Sale | 844 | 75.2779 | 63,535 | D |
03 Mar 2023 16:13 | NVCR | NovoCure Ltd | LEONARD FRANK X | President, CNS Cancers US | 02 Mar 2023 | Sale | 308 | 76.0511 | 23,424 | D |
03 Mar 2023 16:13 | NVCR | NovoCure Ltd | LEONARD FRANK X | President, CNS Cancers US | 02 Mar 2023 | Sale | 3,799 | 75.3235 | 286,154 | D |
02 Mar 2023 17:01 | NVCR | NovoCure Ltd | LEONARD FRANK X | President, CNS Cancers US | 01 Mar 2023 | Sale | 1,684 | 76.3624 | 128,594 | D |
09 Jan 2023 18:21 | NVCR | NovoCure Ltd | LEONARD FRANK X | President, CNS Cancers US | 05 Jan 2023 | Sale | 7,183 | 120 | 861,960 | D |
09 Jan 2023 18:21 | NVCR | NovoCure Ltd | LEONARD FRANK X | President, CNS Cancers US | 05 Jan 2023 | Sale | 7,183 | 114.0001 | 818,863 | D |
09 Jan 2023 18:21 | NVCR | NovoCure Ltd | LEONARD FRANK X | President, CNS Cancers US | 05 Jan 2023 | Sale | 5,517 | 108 | 595,836 | D |
09 Jan 2023 18:21 | NVCR | NovoCure Ltd | LEONARD FRANK X | President, CNS Cancers US | 05 Jan 2023 | Sale | 7,500 | 108 | 810,000 | D |
09 Jan 2023 18:21 | NVCR | NovoCure Ltd | LEONARD FRANK X | President, CNS Cancers US | 05 Jan 2023 | Sale | 7,826 | 108 | 845,208 | D |
09 Jan 2023 18:21 | NVCR | NovoCure Ltd | LEONARD FRANK X | President, CNS Cancers US | 05 Jan 2023 | Sale | 1,010 | 117 | 118,170 | D |
09 Jan 2023 18:21 | NVCR | NovoCure Ltd | LEONARD FRANK X | President, CNS Cancers US | 05 Jan 2023 | Sale | 526 | 115.0348 | 60,508 | D |
09 Jan 2023 18:21 | NVCR | NovoCure Ltd | LEONARD FRANK X | President, CNS Cancers US | 05 Jan 2023 | Sale | 417 | 108 | 45,036 | D |
09 Jan 2023 18:21 | NVCR | NovoCure Ltd | LEONARD FRANK X | President, CNS Cancers US | 05 Jan 2023 | Sale | 2,345 | 119.0077 | 279,073 | D |
17 Oct 2022 16:35 | NVCR | NovoCure Ltd | LEONARD FRANK X | President, CNS Cancers US | 13 Oct 2022 | Sale | 6,754 | 76.01 | 513,372 | D |
07 Oct 2022 16:16 | NVCR | NovoCure Ltd | LEONARD FRANK X | President, CNS Cancers US | 06 Oct 2022 | Sale | 6,754 | 84.37 | 569,835 | D |
30 Sep 2022 16:20 | NVCR | NovoCure Ltd | LEONARD FRANK X | President, CNS Cancers US | 29 Sep 2022 | Sale | 6,754 | 77.35 | 522,422 | D |
26 Sep 2022 16:19 | NVCR | NovoCure Ltd | LEONARD FRANK X | President, CNS Cancers US | 22 Sep 2022 | Sale | 6,754 | 77 | 520,058 | D |
19 Sep 2022 16:10 | NVCR | NovoCure Ltd | LEONARD FRANK X | Chief Development Officer | 15 Sep 2022 | Sale | 5,517 | 90 | 496,530 | D |
19 Sep 2022 16:10 | NVCR | NovoCure Ltd | LEONARD FRANK X | Chief Development Officer | 15 Sep 2022 | Sale | 6,754 | 87.31 | 589,692 | D |
12 Sep 2022 16:32 | NVCR | NovoCure Ltd | LEONARD FRANK X | Chief Development Officer | 09 Sep 2022 | Sale | 1,863 | 88 | 163,944 | D |
13 Sep 2022 16:15 | NVCR | NovoCure Ltd | LEONARD FRANK X | Chief Development Officer | 08 Sep 2022 | Sale A | 6,754 | 81.48 | 550,316 | D |
07 Sep 2022 16:27 | NVCR | NovoCure Ltd | LEONARD FRANK X | Chief Development Officer | 06 Sep 2022 | Sale | 1,384 | 78.57 | 108,741 | D |
06 Sep 2022 16:19 | NVCR | NovoCure Ltd | LEONARD FRANK X | Chief Development Officer | 02 Sep 2022 | Sale | 584 | 79.037 | 46,158 | D |
06 Sep 2022 16:19 | NVCR | NovoCure Ltd | LEONARD FRANK X | Chief Development Officer | 01 Sep 2022 | Sale | 48 | 78.956 | 3,790 | D |
06 Sep 2022 16:19 | NVCR | NovoCure Ltd | LEONARD FRANK X | Chief Development Officer | 01 Sep 2022 | Sale | 438 | 78.14 | 34,225 | D |
06 Sep 2022 16:19 | NVCR | NovoCure Ltd | LEONARD FRANK X | Chief Development Officer | 01 Sep 2022 | Sale | 360 | 77.062 | 27,742 | D |
06 Sep 2022 16:19 | NVCR | NovoCure Ltd | LEONARD FRANK X | Chief Development Officer | 01 Sep 2022 | Sale | 240 | 75.875 | 18,210 | D |
06 Sep 2022 16:19 | NVCR | NovoCure Ltd | LEONARD FRANK X | Chief Development Officer | 01 Sep 2022 | Sale | 1,088 | 78.678 | 85,602 | D |
06 Sep 2022 16:19 | NVCR | NovoCure Ltd | LEONARD FRANK X | Chief Development Officer | 01 Sep 2022 | Sale | 2,720 | 77.917 | 211,934 | D |
06 Sep 2022 16:19 | NVCR | NovoCure Ltd | LEONARD FRANK X | Chief Development Officer | 01 Sep 2022 | Sale | 1,750 | 76.958 | 134,676 | D |
06 Sep 2022 16:19 | NVCR | NovoCure Ltd | LEONARD FRANK X | Chief Development Officer | 01 Sep 2022 | Sale | 1,200 | 75.928 | 91,114 | D |
06 Sep 2022 16:19 | NVCR | NovoCure Ltd | LEONARD FRANK X | Chief Development Officer | 01 Sep 2022 | Sale | 452 | 78.663 | 35,556 | D |
06 Sep 2022 16:19 | NVCR | NovoCure Ltd | LEONARD FRANK X | Chief Development Officer | 01 Sep 2022 | Sale | 2,955 | 78.085 | 230,741 | D |
06 Sep 2022 16:19 | NVCR | NovoCure Ltd | LEONARD FRANK X | Chief Development Officer | 01 Sep 2022 | Sale | 1,914 | 77.002 | 147,382 | D |
06 Sep 2022 16:19 | NVCR | NovoCure Ltd | LEONARD FRANK X | Chief Development Officer | 01 Sep 2022 | Sale | 1,047 | 75.935 | 79,504 | D |
03 Aug 2022 16:44 | NVCR | NovoCure Ltd | LEONARD FRANK X | Chief Development Officer | 02 Aug 2022 | Sale | 414 | 69.659 | 28,839 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)